KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseExpense - Property Taxes and InsuranceExpense - Property and MaintenanceLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherRevenue - Mortgage Backed SecuritiesRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

National Health Investors (NHI) Shares Issued (2016 - 2025)

National Health Investors filings provide 15 years of Shares Issued readings, the most recent being $46.6 million for Q4 2025.

  • On a quarterly basis, Shares Issued fell 67.27% to $46.6 million in Q4 2025 year-over-year; TTM through Mar 2026 was $116.0 million, a 44.17% decrease, with the full-year FY2025 number at $181.5 million, up 27.49% from a year prior.
  • Shares Issued hit $46.6 million in Q4 2025 for National Health Investors, up from $11.4 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $142.4 million in Q4 2024 to a low of -$47000.0 in Q2 2021.
  • Median Shares Issued over the past 3 years was $47.3 million (2021), compared with a mean of $46.5 million.
  • The widest YoY moves for Shares Issued: up 55216.09% in 2021, down 100.01% in 2021.
  • National Health Investors' Shares Issued stood at -$4000.0 in 2021, then surged by 3559950.0% to $142.4 million in 2024, then crashed by 67.27% to $46.6 million in 2025.
  • The last three reported values for Shares Issued were $46.6 million (Q4 2025), $11.4 million (Q3 2025), and $58.0 million (Q2 2025) per Business Quant data.